Common ophthalmic problems of urban and rural postmenopausal women in a population sample of Raciborz district, a RAC-OST-POL Study
More details
Hide details
Department and Clinic of Ophthalmology, Medical University of Silesia, Katowice, Poland
Department of Pathomorphology, Medical University of Silesia, Katowice, Poland
Department of Nephrology, Raciborz, Poland
Department and Clinic of Internal Diseases, Diabetology and Nephrology, Medical University of Silesia, Katowice, Poland
Department of Anaesthesiology and Intensive Care, Medical University of Silesia, Poland
KCR S.A., Warsaw, Poland
Department and Clinic of Internal Diseases, Diabetology and Nephrology, Metabolic Bone Diseases Unit, Medical University of Silesia, Katowice, Poland
Ann Agric Environ Med. 2014;21(1):70–74
Introduction and objective:
We wished to establish the prevalence of eye diseases and eye disease risk factors at postmenopausal age and to compare ophthalmic problems in urban and rural areas of Raciborz.

Patients and methods:
The study was performed in 2010. Out of the whole population of Raciborz, Poland, 10 percent (1750) of women were randomly selected for the reported study. Finally, ocular diseases, ophthalmic agents, health status (physical activity level, body mass index – BMI, reproductive history, the use of psychotropic drugs and hormone replacement therapy – HRT) were recorded in 623 women. The women underwent visual acuity test and anterior segment examination, applanation tonometry and indirect ophthalmoscopy.

The mean age of the selected patients was 66.01±7.76 years, 275 (44%) of them originating from rural and 348 (56%) from urban regions. The average woman was obese (BMI=30.54±5.38 kg/m2), with near normal agility and reproductive history of 2.59±1.55 births, 147 (24%) subjects remained under regular HRT support. According to the WHO, the visual acuity was classified as normal or near normal in 87.5%, while no blindness was recorded at all. Visual acuity depended, first of all, on lens status and was better among subjects with good agility (R=-0.31, p=0.001). Dry eye prevalence increased significantly over age of 67 years (p=0.000) and HRT seemed to be a dry eye protective factor (p=0.010). Except age, No other risk factors of cataract, other than age, were identified. Normal agility (p=0.003) and HRT (p=0.032) were associated with lower AMD (age-related macular degeneration) prevalence rates. The differences between urban and rural participants were presented only in education, reproductive history, hypertension and frequency of ophthalmic examinations.

Older adult women living in neighboring urban and rural areas present no differential in ophthalmic health problems.

Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye 2005; 19: 1133–1135.
Congdon NG, Friedman DS et al.Important causes of visual impairment in the world today. JAMA 2003; 290: 2057–2060.
Sharts-Hopko NC. Lifestyle strategiesforthe prevention of vision loss. Holist Nurs Pract. 2010; 5: 284–291.
Paunksnis A, Kusleika S et al. The relationship of the intensity of lens opacity with physical activity. Medicina. 2006; 42: 738–743.
Mares JA, Voland RP et al. Healthy lifestyles related to subsequent prevalence of age-relatedmacular degeneration.ArchOphthalmol. 2010; 13.
Schaumberg DA, Sullivan DA et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003; 136: 318–326.
Snow KK, Seddon JM. Age-related eye diseases: impact of hormone replacement therapy, and reproductive and other risk factors. Int J Fertil Womens Med. 2000; 45: 301–313.
Klein R, Klein BEK et al. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992; 99: 933–943.
Pasquale LR, Rosner BA et al. Attributes of female reproductive aging and theirrelation to primary open-angle glaucoma: a prospective study. J Glaucoma. 2007; 16: 598–605.
Battaglia C, Mancini F et al. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 2004; 11: 69–77.
Podsiadlo D, Richardson S. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons J Am Geriatr Soc. 1991; 39: 142–148.
Thylefors B, Chylack LT Jr et al. A simplified cataract grading system. Ophthalmic Epidemiol. 2002; 9: 83–95.
World Health Organisation. International statistical classification of diseases and related health problems. Geneva: WHO1992.
Olszanecka A, Posnik-Urbańska A et al. Adipocytokines and blood pressure, lipids and glucose metabolism in hypertensive perimenopausal women. Kardiol Pol. 2010; 68: 753–760.
Rosenberg L, Czene K et al. Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? BrJCancer 2009; 100: 1486–1491.
Dionyssiotis Y, GalanosAet al. Assessment of musculoskeletalsystem in women with jumping mechanography. Int J Women Health 2010; 1: 113–118.
Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 2009; 3: 405–412.
Taner P, Akarsu C et al. The effects of hormone replacement therapy on ocular surface and tear function tests in postmenopausal women. Ophthalmologica 2004; 218: 257–259.
Altintaş O, Caglar Y, Yüksel N et al. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004; 218: 120–129.
Erdem U, Ozdegirmenci O et al. Dry eye in post-menopausal women using hormone replacement therapy. Maturitas 2007; 56: 257–262.
Noran NH, Salleh N et al. Relationship between reproductive exposures and age-related cataract in women. Asia Pac J Public Health 2007; 19: 23–28.
Aina FO, Smeeth L et al. Hormone replacement therapy and cataract: a population-based case-control study. Eye 2006; 20: 417–422.
Klein BE, Klein R et al. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study. Am J Ophthalmol. 2000; 130: 322–326.
Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res. 2012; 47: 171–188.
Edwards DR, Gallins P et al. Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms. Invest Ophthalmol Vis Sci. 2010; 51: 1873–1879.
The Eye DiseaseCase-Control Study Group. Risk factorsfor neovascular age-related macular degeneration. Arch Ophthalmol. 1992; 110: 1701– 1708.
SnowKK,Cote J et al.Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol. 2002; 134: 842–848.
Williams PT. Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up. Invest Ophthalmol Vis Sci. 2009; 50: 101–106.
Nizankowska MH, Kaczmarek R. Prevalence of glaucoma in the Wroclawpopulation.The Wroclawepidemiologicalstudy. Ophthalmic Epidemiol. 2005; 12: 363–371.
Richa S, Yazbek JC. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs 2010; 24: 501–526.